Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 4
2010 1
2011 3
2012 14
2013 16
2014 7
2015 4
2016 1
2017 8
2018 10
2019 11
2020 12
2021 12
2022 10
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA. Flaig TW, et al. Among authors: abern m. J Natl Compr Canc Netw. 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041. J Natl Compr Canc Netw. 2022. PMID: 35948037
Estrogens and prostate cancer.
Dobbs RW, Malhotra NR, Greenwald DT, Wang AY, Prins GS, Abern MR. Dobbs RW, et al. Among authors: abern mr. Prostate Cancer Prostatic Dis. 2019 May;22(2):185-194. doi: 10.1038/s41391-018-0081-6. Epub 2018 Aug 21. Prostate Cancer Prostatic Dis. 2019. PMID: 30131606 Review.
EDITORIAL COMMENT.
Vigneswaran H, Abern M. Vigneswaran H, et al. Among authors: abern m. Urology. 2021 Jan;147:221-222. doi: 10.1016/j.urology.2020.07.069. Urology. 2021. PMID: 33390205 No abstract available.
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.
Carbunaru S, Sun Z, McCall C, Ofori B, Marshall N, Wang H, Abern M, Liu L, Hollowell CMP, Sharifi R, Vidal P, Kajdacsy-Balla A, Sekosan M, Ferrer K, Wu S, Gallegos M, Gann PH, Moreira D, Sharp LK, Ferrans CE, Murphy AB. Carbunaru S, et al. Among authors: abern m. Cancer Med. 2023 Oct;12(19):19690-19700. doi: 10.1002/cam4.6615. Epub 2023 Oct 3. Cancer Med. 2023. PMID: 37787097 Free PMC article. Clinical Trial.
Ureteral mullerianosis.
Abern MR, Benson JS, Hoeksema J. Abern MR, et al. J Endourol. 2009 Dec;23(12):1933-5. doi: 10.1089/end.2009.0321. J Endourol. 2009. PMID: 19916755 No abstract available.
Biparametric Quantitative MRI for Prostate Cancer Detection.
Uyanik M, Vigneswaran HT, Hale GR, Gann P, Magin R, Abern MR. Uyanik M, et al. Among authors: abern mr. Top Magn Reson Imaging. 2023 Dec 1;32(6):66-72. doi: 10.1097/RMR.0000000000000308. Epub 2023 Nov 15. Top Magn Reson Imaging. 2023. PMID: 38051029 Free PMC article.
97 results